Advertisement
Advertisement

Flavoxate


Generic Medicine Info
Indications and Dosage
Oral
Dysuria, Urinary incontinence, urgency and frequency
Adult: For the symptomatic relief in patients with cystitis, prostatitis, urethritis, urethrocystitis or urethrotrigonitis: 200 mg tid. Alternatively, 100-200 mg 3-4 times daily, may be reduced if symptoms improve. Dosage and treatment recommendations may vary among individual products and between countries (refer to specific product guidelines).
Child: ≥12 years Same as adult dose.

Oral
Bladder spasms due to catheterisation
Adult: 200 mg tid. Treatment recommendations may vary among individual products and between countries (refer to specific product guidelines).
Child: ≥12 years Same as adult dose.
What are the brands available for Flavoxate in Singapore?
Other Known Brands
  • Cleanxate
Administration
Flavoxate May be taken with or without food.
Flavoxate hydrochloride Should be taken with food.
Contraindications
Pyloric or duodenal obstruction, ileus, obstructive intestinal lesions, obstructive uropathies of lower urinary tract, gastrointestinal haemorrhage, myasthenia gravis, glaucoma, achalasia, urinary retention.
Special Precautions
Patient with suspected glaucoma. Renal impairment. Children and elderly. Pregnancy and lactation.
Adverse Reactions
Blood and lymphatic system disorders: Eosinophilia, leucopenia.
Cardiac disorders: Palpitations, tachycardia.
Eye disorders: Visual impairment, blurred vision, glaucoma.
Gastrointestinal disorders: Nausea, vomiting, xerostomia, dyspepsia.
General disorders and administration site conditions: Hyperpyrexia.
Immune system disorders: Hypersensitivity.
Nervous system disorders: Drowsiness, headache, nervousness, vertigo.
Psychiatric disorders: Somnolence.
Renal and urinary disorders: Dysuria.
Skin and subcutaneous tissue disorders: Rash, erythema.
Patient Counseling Information
This drug may cause drowsiness, vertigo, and blurred vision, if affected, do not drive or operate machinery.
Monitoring Parameters
Monitor urinary frequency and urgency. Monitor for signs and symptoms of anticholinergic effects.
Drug Interactions
Enhanced antimuscarinic effects (e.g. dry mouth, urinary retention, constipation) with other antimuscarinic agents.
Food Interaction
Enhanced CNS effects with alcohol.
Action
Description:
Mechanism of Action: Flavoxate, a tertiary amine, has a direct antispasmodic action on smooth muscles, resulting in relief of muscle spasms. It also increases urinary bladder capacity in patients with bladder spasticity.
Onset: 55 minutes.
Pharmacokinetics:
Absorption: Readily absorbed from the gastrointestinal tract.
Metabolism: Rapidly metabolised mainly into methyl flavone carboxylic acid (MFCA).
Excretion: Via urine (approx 50-60% as MFCA).
Chemical Structure

Chemical Structure Image
Flavoxate

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 3354, Flavoxate. https://pubchem.ncbi.nlm.nih.gov/compound/Flavoxate. Accessed Oct. 28, 2024.

Storage
Store below 30°C. Protect from light.
MIMS Class
Drugs for Bladder & Prostate Disorders
ATC Classification
G04BD02 - flavoxate ; Belongs to the class of urinary antispasmodics.
References
Anon. Flavoxate Hydrochloride. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 02/10/2024.

Brayfield A, Cadart C (eds). Flavoxate Hydrochloride. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 02/10/2024.

Flavoxate Hydrochloride Tablets 100 mg, Film-coated (Epic Pharma, LLC). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 02/10/2024.

Flavoxate. UpToDate Lexidrug, Lexi-Drugs Multinational Online. Waltham, MA. UpToDate, Inc. https://online.lexi.com. Accessed 02/10/2024.

Joint Formulary Committee. Flavoxate Hydrochloride. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 02/10/2024.

Urispas 200 mg Film-coated Tablets (Recordati Pharmaceuticals Limited). MHRA. https://products.mhra.gov.uk. Accessed 02/10/2024.

Uroxate Tablet 100 mg (Imeks Pharma Sdn. Bhd.). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my. Accessed 02/10/2024.

Disclaimer: This information is independently developed by MIMS based on Flavoxate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2025 MIMS. All rights reserved. Powered by MIMS.com
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement